-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
- 2014 Nian 7 May 22 to May 17, 2018, 261 participants entered the open-label phase
Literature source: Kehoe PG, Turner N, Howden B, et al.
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet Neurol.
2021;20(11):895-906.
doi:10.
1016/S1474-4422(21)00263-5 Kehoe PG, Turner N, Howden B, et al.
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet Neurol.
2021;20(11):895-906.
doi:10.
1016/S1474-4422( 21)00263-5
Leave a message here